ALS patients improve after stem cell treatment

Israel’s BrainStorm reported positive interim results of Phase IIa ALS trials of its “NurOwn” stem cell therapy. 71% of patients were in decline before treatment but after treatment 63% were either stabilized or had improved neurological function.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *